Jw Pharmac (001060) — Cash Flow Quality Index
Jw Pharmac (001060) has a Cash Flow Quality Index of 1.80x as of December 2025. Operating cash flow of ₩27.55 Billion exceeds net income of ₩15.32 Billion, indicating high earnings quality where cash backs reported profits. Explore Jw Pharmac (001060) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jw Pharmac Cash Flow Quality Index (2001–2025)
Historical Cash Flow Quality Index for Jw Pharmac across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Jw Pharmac (001060) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jw Pharmac (2001–2025)
Year-by-year earnings quality comparison for Jw Pharmac. For live market cap and the full company financial profile, see 001060 stock market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.57x | ₩96.40 Billion | ₩61.51 Billion | ▲ +28.4% |
| 2024 | 1.22x | ₩79.39 Billion | ₩65.04 Billion | ▼ -51.2% |
| 2023 | 2.50x | ₩87.16 Billion | ₩34.84 Billion | ▲ +47.8% |
| 2022 | 1.69x | ₩56.76 Billion | ₩33.55 Billion | ▼ -73.8% |
| 2018 | 6.47x | ₩52.11 Billion | ₩8.06 Billion | ▲ +403.9% |
| 2015 | -2.13x | ₩-4.17 Billion | ₩1.96 Billion | ▼ -118.0% |
| 2014 | 11.80x | ₩7.28 Billion | ₩617.05 Million | ▲ +41.4% |
| 2013 | 8.34x | ₩18.72 Billion | ₩2.24 Billion | ▲ +1814.8% |
| 2006 | 0.44x | ₩5.07 Billion | ₩11.65 Billion | ▼ -94.4% |
| 2005 | 7.74x | ₩70.25 Billion | ₩9.08 Billion | ▲ +548.9% |
| 2004 | 1.19x | ₩15.02 Billion | ₩12.59 Billion | ▼ -25.1% |
| 2003 | 1.59x | ₩17.05 Billion | ₩10.71 Billion | ▼ -39.7% |
| 2002 | 2.64x | ₩28.74 Billion | ₩10.89 Billion | ▼ -39.9% |
| 2001 | 4.39x | ₩45.04 Billion | ₩10.26 Billion | — |